Psychopharmacology
-
Randomized Controlled Trial
A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia.
A growing body of evidence illustrates that 5-HT3 receptor antagonist drugs may be of benefit in the treatment of negative symptoms in schizophrenia. ⋯ Tropisetron add-on to risperidone improves the primary negative symptoms of patients with chronic stable schizophrenia.